BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 21188446)

  • 1. Efficacy and Prolonged Safety of
    Tripathi N; Mukherjee S
    Infect Disord Drug Targets; 2024; 24(5):e150124225640. PubMed ID: 38231056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological protection induced by Haemophilus influenzae Type B conjugate vaccine in Mexican children: is a booster dose of the vaccine needed?
    Rodriguez RS; Mascarenas C; Conde-Glez CJ; Inostroza J; Villanueva S; Velázquez ME; Sánchez-Alemán MA; Echániz G
    Clin Vaccine Immunol; 2010 Oct; 17(10):1639-41. PubMed ID: 20719986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CAPITA study of protein-conjugate pneumococcal vaccine and its implications for use in adults in developed countries.
    Musher DM; Rodriguez-Barradas MC
    Hum Vaccin Immunother; 2014; 10(5):1331-3. PubMed ID: 24786644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress towards demonstrating the impact of Haemophilus influenzae type b conjugate vaccines globally.
    Hajjeh R; Mulholland K; Schuchat A; Santosham M
    J Pediatr; 2013 Jul; 163(1 Suppl):S1-3. PubMed ID: 23773587
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b.
    Fernández-Santana V; Cardoso F; Rodriguez A; Carmenate T; Peña L; Valdés Y; Hardy E; Mawas F; Heynngnezz L; Rodríguez MC; Figueroa I; Chang J; Toledo ME; Musacchio A; Hernández I; Izquierdo M; Cosme K; Roy R; Verez-Bencomo V
    Infect Immun; 2004 Dec; 72(12):7115-23. PubMed ID: 15557635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high throughput serum bactericidal assay for antibodies to Haemophilus influenzae type b.
    Kim HW; Kim KH; Kim J; Nahm MH
    BMC Infect Dis; 2016 Sep; 16(1):473. PubMed ID: 27595992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilus influenzae Non-type b Infection in an Adult Patient with Systemic Lupus Erythematosus.
    Hasegawa Y; Arinuma Y; Tanaka S; Tono T; Tanaka T; Muramatsu T; Kondo J; Matsueda Y; Hoshiyama T; Wada T; Takayama Y; Yamaoka K
    Intern Med; 2020 Dec; 59(23):3097-3101. PubMed ID: 32759581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Pseudooligosaccharides Related to the Capsular Phosphoglycan of
    Kamneva AA; Yashunsky DV; Khatuntseva EA; Nifantiev NE
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Contribution to the Bacteriological Study of B. Influenzae.
    War Med (Paris); 1918 Nov; 2(4):610-612. PubMed ID: 37757003
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating innate and adaptive immunity against anti-Haemophilus influenzae type b.
    Zarei AE; Linjawi MH; Redwan EM
    Hum Antibodies; 2019; 27(3):201-212. PubMed ID: 30958343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugate Haemophilus influenzae type b vaccines for sickle cell disease.
    Allali S; Chalumeau M; Launay O; Ballas SK; de Montalembert M
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011199. PubMed ID: 26881484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease.
    Ishiwada N; Honda Y; Tanaka J; Hishiki H; Kohno Y
    J Infect Chemother; 2011 Jun; 17(3):397-400. PubMed ID: 21188446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
    Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
    Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
    Suga S; Ishiwada N; Sasaki Y; Akeda H; Nishi J; Okada K; Fujieda M; Oda M; Asada K; Nakano T; Saitoh A; Hosoya M; Togashi T; Matsuoka M; Kimura K; Shibayama K
    Vaccine; 2018 Sep; 36(38):5678-5684. PubMed ID: 30122645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children who failed to respond to prior invasive H. influenzae type b disease.
    Berthet F; Prehn A; Suter R; Ethevenaux C; Seger RA
    Pediatr Allergy Immunol; 1998 Aug; 9(3):156-60. PubMed ID: 9814731
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.